These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 3839286)
1. Calciuric response to 1,25-(OH)2D3 in early renal failure. Cremer B; Lübbers E; Klooker P; Schmidt-Gayk H; Ritz E Miner Electrolyte Metab; 1985; 11(3):182-5. PubMed ID: 3839286 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. Do limited changes in phosphate intake modulate 1,25(OH)2D3 levels in early renal failure? Seidel A; Stein G; Schneider S; Schmidt-Gayk H; Ritz E Clin Nephrol; 1991 Dec; 36(6):274-80. PubMed ID: 1769138 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862 [TBL] [Abstract][Full Text] [Related]
5. Single-dose oral calcitriol and changes of plasma 1,84iPTH in uremic children. Klaus G; Schmidt-Gayk H; Roth HJ; Ritz E; Mehls O Adv Perit Dial; 1994; 10():261-6. PubMed ID: 7999841 [TBL] [Abstract][Full Text] [Related]
6. Long-term low-dose calcitriol treatment in predialysis chronic renal failure: can it prevent hyperparathyroid bone disease? Nordal KP; Dahl E; Halse J; Attramadal A; Flatmark A Nephrol Dial Transplant; 1995; 10(2):203-6. PubMed ID: 7753453 [TBL] [Abstract][Full Text] [Related]
7. Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure. Panichi V; Andreini B; De Pietro S; Migliori M; Taccola D; Giovannini L; Ferdeghini M; Palla R Clin Nephrol; 1998 Apr; 49(4):245-50. PubMed ID: 9582556 [TBL] [Abstract][Full Text] [Related]
8. Renal function during calcitriol therapy in chronic renal failure. Bertoli M; Luisetto G; Ruffatti A; Urso M; Romagnoli G Clin Nephrol; 1990 Feb; 33(2):98-102. PubMed ID: 2311310 [TBL] [Abstract][Full Text] [Related]
9. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate]. Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857 [TBL] [Abstract][Full Text] [Related]
10. [Chronic kidney insufficiency and respiratory muscle function. Changes induced by treatment with 1,25(OH)2D3]. Gómez-Fernández P; Sánchez Agudo L; Calatrava JM Med Clin (Barc); 1990 Feb; 94(6):204-7. PubMed ID: 2329853 [TBL] [Abstract][Full Text] [Related]
11. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure. Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483 [TBL] [Abstract][Full Text] [Related]
12. Effects of long-term therapy with calcitriol in patients with moderate renal failure. Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118 [TBL] [Abstract][Full Text] [Related]
13. [Effect of 24,25-dioxycholecalciferol on calcium-phosphorus metabolism and bone tissue in rats with experimental renal failure]. Alekseeva IA Vopr Pitan; 1984; (3):55-8. PubMed ID: 6332422 [TBL] [Abstract][Full Text] [Related]
14. [Comparative study of the effects of alpha-25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol on calcium-phosphorus metabolism and on bone tissue in experimental kidney insufficiency in rats]. Alekseeva AI; Spirichev VB; Bogoslovskiĭ NA; Kisel'nikova TA Vopr Med Khim; 1983; 29(5):103-12. PubMed ID: 6606264 [TBL] [Abstract][Full Text] [Related]